Molecular Characterization and Patient Outcome of Melanoma Nodal Metastases and an Unknown Primary Site
Open Access
- 28 May 2014
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (13) , 4317-4323
Abstract
Melanoma of unknown primary site (MUP) is not a completely understood entity with nodal metastases as the most common first clinical manifestation. The aimKeywords
This publication has 39 references indexed in Scilit:
- Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literatureCritical Reviews in Oncology/Hematology, 2011
- Melanoma without a Detectable Primary Site with Metastases to Lymph NodesDermatologic Surgery, 2010
- Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implicationsJournal of Carcinogenesis, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary MelanomaJournal of Clinical Oncology, 2008
- Somatic Activation of KIT in Distinct Subtypes of MelanomaJournal of Clinical Oncology, 2006
- Metastatic melanoma to lymph nodes in patients with unknown primary sitesCancer, 2006
- Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer InstituteMelanoma Research, 2005
- Improved Long-term Survival After Lymphadenectomy of Melanoma Metastatic to Regional NodesAnnals of Surgery, 1991
- Lymph node metastasis from melanoma with an unknown primary siteBritish Journal of Surgery, 1990